表紙
市場調査レポート

小動物体内撮影の世界市場:装置・試薬(マイクロPET、光学撮影、マイクロMRI、マイクロSPECT、マイクロ超音波、マイクロCT、マルチモダリティ/ハイブリッド撮影モダリティ)別競合分析および市場予測

Small Animal Imaging (In Vivo) Market - By Systems & Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017

発行 MarketsandMarkets 商品コード 260669
出版日 ページ情報 英文 276 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
小動物体内撮影の世界市場:装置・試薬(マイクロPET、光学撮影、マイクロMRI、マイクロSPECT、マイクロ超音波、マイクロCT、マルチモダリティ/ハイブリッド撮影モダリティ)別競合分析および市場予測 Small Animal Imaging (In Vivo) Market - By Systems & Reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017
出版日: 2013年01月28日 ページ情報: 英文 276 Pages
概要

小動物体内撮影が研究の最終段階から臨床段階までの間で実施頻度を増しています。特定の薬剤候補や治療計画の評価において画像は、表現型検査やさまざまな疾患の病態生理学理解に重要な役割を担うようになったのです。小動物体内撮影に利用される技術は、同一動物体内で疾患の薬物療法だけでなく、経時的評価を可能にすることから、研究活動における作業効率を高めるとともに、検体の個体数の低減につながります。同技術の2012年市場規模は世界全体で、7億8940万ドルと推定され、以降14.5%の複合年間成長率を維持しながら、2017年には15億5170万ドルに達する見込みです。

当レポートでは、こうした小動物体内撮影市場に注目し、その現況と将来性、発展へのさまざまな影響ファクターと機会、競合環境などを把握するための最新調査情報を集めて、概略以下の構成でお届けします。

第1章 イントロダクション

  • 重要所見
  • レポートの説明
  • 調査対象市場
  • 対象利用者層
  • 調査方法
    • 市場規模
    • 市場シェア
    • 二次情報源から得られたデータの主要ポイント
    • 一次情報源から得られたデータの主要ポイント
    • 前提条件

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • 市場セグメンテーション
    • 小動物(体内)撮影市場 - 技術別
    • 小動物(体内)撮影市場 - 試薬別
  • 市場動態
    • 推進要因
    • 抑制要因
    • 機会
    • 課題
    • 市場シェア分析

第4章 世界小動物(体内)撮影市場 - 技術別

  • イントロダクション
  • 小動物(体内)撮影のスタンドアロン技術
    • 放射性撮影
    • 光学撮影
    • マイクロMRI
    • マイクロCT
    • マイクロ超音波
  • マルチモーダル光学撮影装置

第5章 世界小動物(体内)撮影市場 - 試薬別

  • イントロダクション
  • 小動物(体内)画像の放射性撮影
    • PETトレーサー
    • SPECTプローブ
  • 小動物(体内)画像の光学撮影
    • 生物発光
    • 蛍光発光
  • 小動物(体内)撮影用MRIコントラスト試薬
    • ガドリニウム系
    • 鉄系
  • 小動物(体内)撮影用CTコントラスト試薬
    • ヨウ素系
    • バリウム系
    • ガストログラフイン系
  • 小動物(体内)撮影用超音波コントラスト試薬
    • GOAM

第6章 地域別分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋州
  • その他の地域(ROW)

第7章 競合環境

  • イントロダクション

第8章 企業プロフィール

目次
Product Code: MD1414

The report is based on the extensive research study of the facial recognition market and the related submarket within the ecosystem. The report is focused to give a birds eye-view of the complete facial recognition industry with regards to technology and solutions, software, hardware and services. It also provides revenue distribution of the market based on various industry vertical or end-users. The report provides a unique view of the facial recognition market and how the market will evolve by 2018.

MarketsandMarkets has segmented the face recognition market by types of technologies and solutions, components (hardware, software and services), industry verticals or end-users and regions. The technology and solutions segment comprises of 2D, 3D, thermal, emotion, mobile and forensic technology. The software segmented is further segmented by face recognition algorithms/SDK, middleware, database, modelling and analytic softwares. Under the services segment the report covers consulting and cloud-based services. The technology and components markets, along with each of their sub-segments are further bifurcated by regions. Regions covered include North America (NA), Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and Latin America (LA).

We have also profiled leading players of this industry with their recent developments and other strategic industry activities. Key players profiled include NEC, Cognitec Systems, Safran Group (Morpho), 3M, Animetrics, ZK Software, RCG Holdings, Cross Match Technologies , Merkatum Corporation. A complete competitive landscape, along with key growth strategies of the key industry players has also been provided.

This research report categorizes the global market for face recognition to forecast the revenues and analyze the trends in each of the following sub-markets:

On the basis of technology and solutions: 2D, 3D, thermal, emotion, forensic and mobile facial recognition technologies

On the basis of components: Hardware, software and services

On the basis of software types: Face recognition algorithm/SDK, middleware, database, modeling and restructuring and analytics software

On the basis of service types: Consulting services and cloud-based services

On the basis of end-users: Government and public utilities, enterprises, and consumer and home

On the basis of regions: North America, APAC, Europe, MEA and Latin America

SCOPE OF THE REPORT

Global small animal imaging (in vivo) market, by Technology:

Standalone Technology

  • Nuclear imaging
    • MicroSPECT (Single photon emission computed tomography)
    • MicroPET (Positron emission tomography)
  • Optical imaging
    • Fluorescence
    • Bioluminescence
    • Near Infrared fluorescence
  • Micro-MRI
  • Micro-CT
  • Micro-Ultrasound

Multimodality Technology

  • Multimodal Nuclear imaging devices
    • SPECT+CT
    • SPECT+MR
    • PET+CT
    • PET+MR
    • SPECT+PET+CT
  • Multimodal Optical imaging devices
    • Optical + X-ray+ Radioisotopic

Global small animal imaging (in vivo) market, by reagents:

Nuclear imaging

  • PET Tracers
    • Fluorine-18 based
    • Carbon-11 based
    • Copper-64 based
    • Others
  • SPECT probes
    • Technetium-99m based
    • Iodine-131 based
    • Gallium-67 based
    • Thallium-201 based
    • Others

Optical imaging

  • Bioluminescence
    • Luciferins
    • Proluciferins
    • coelenterazine
    • Others
  • Fluoresence
    • Green fluorescent proteins
    • Red fluorescent proteins
    • Infrared dyes
    • Others (natural fluoresence molecules such as collagen and elastin)

MRI contrasting reagents

  • Gadolinium based
  • Iron based

CT contrast reagents

  • Iodine based
  • Barium based
  • Gastrografin based

Ultrasound contrast reagents

Global small animal imaging (in vivo) market, by geography:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

1. INTRODUCTION

  • 1.1. KEY TAKE-AWAYS
  • 1.2. REPORT DESCRIPTION
  • 1.3. STAKEHOLDERS
  • 1.4. RESEARCH METHODOLOGY
    • 1.4.1. MARKET SIZE
    • 1.4.2. MARKET SHARE
    • 1.4.3. KEY DATA POINTS FROM SECONDARY SOURCES
    • 1.4.4. KEY DATA POINTS FROM PRIMARY SOURCES
    • 1.4.5. ASSUMPTIONS

2. EXECUTIVE SUMMARY

3. MARKET OVERVIEW

  • 3.1. INTRODUCTION
  • 3.2. MARKET SEGMENTATION
    • 3.2.1. SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY TECHNOLOGY
    • 3.2.2. SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY REAGENT
  • 3.3. MARKET DYNAMICS
    • 3.3.1. DRIVERS
      • 3.3.1.1. Technological Advancements
      • 3.3.1.2. Growing Adoption Rate for Small animal imaging
      • 3.3.1.3. Rising Application of Functional Imaging
      • 3.3.1.4. Increasing Number of Pharma Companies and Research Institutes
    • 3.3.2. RESTRAINTS
      • 3.3.2.1. High Cost of Devices
      • 3.3.2.2. Technological Limitations
      • 3.3.2.3. High Cost and Data Requirements to Bring in New Technology
    • 3.3.3. OPPORTUNITIES
      • 3.3.3.1. Unique Combinations in MRI
      • 3.3.3.2. High Resolution &Sensitivity of Imaging Devices with Usage in Multiple Applications
      • 3.3.3.3. Emerging Markets
    • 3.3.4. CHALLENGES
      • 3.3.4.1. Sustainability of Players in the Highly Competitive Market
      • 3.3.4.2. Availability of Radiopharmaceuticals
  • 3.4. MARKET SHARE ANALYSIS
    • 3.4.1. BY TECHNOLOGY
    • 3.4.2. BY MARKET PLAYER
    • 3.4.3. BY GEOGRAPHY

4. GLOBAL SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY

  • 4.1. INTRODUCTION
  • 4.2. STANDALONE TECHNOLOGY FOR SMALL ANIMAL IMAGING (IN VIVO)
    • 4.2.1. NUCLEAR IMAGING
      • 4.2.1.1. Micro-SPECT
      • 4.2.1.2. Micro-PET
    • 4.2.2. OPTICAL IMAGING
      • 4.2.2.1. Fluorescence
      • 4.2.2.2. Bioluminescence
      • 4.2.2.3. Near-Infrared Fluorescence
    • 4.2.3. MICRO-MRI
    • 4.2.4. MICRO-CT
    • 4.2.5. MICRO-ULTRASOUND
  • 4.3. MULTIMODAL IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO)
    • 4.3.1. MULTIMODAL NUCLEAR IMAGING DEVICES
      • 4.3.1.1. SPECT/CT
      • 4.3.1.2. SPECT/MR
      • 4.3.1.3. PET/CT
      • 4.3.1.4. PET/MR
      • 4.3.1.5. SPECT/PET/CT
    • 4.3.2. MULTIMODAL OPTICAL IMAGING DEVICES
      • 4.3.2.1. Optical/X-ray/Radioisotopic
      • 4.3.2.2. Cerenkov Luminescence Imaging
        • 4.3.2.2.1. Advantages Of Cerenkov Luminescence Imaging
        • 4.3.2.2.2. Disadvantages of Cerenkov Luminescence Imaging
        • 4.3.2.2.3. Market Dynamics

5. GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY REAGENTS

  • 5.1. INTRODUCTION
  • 5.2. NUCLEAR IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO)
    • 5.2.1. PET TRACERS
      • 5.2.1.1. Fluorine-18 based
      • 5.2.1.2. Carbon-11 based
      • 5.2.1.3. Copper-64 based
      • 5.2.1.4. Others
    • 5.2.2. SPECT PROBES
      • 5.2.2.1. Technetium-99m based
      • 5.2.2.2. Iodine-131 based
      • 5.2.2.3. Gallium-67 based
      • 5.2.2.4. Thallium-201 based
      • 5.2.2.5. Others
  • 5.3. OPTICAL IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO)
    • 5.3.1. BIOLUMINESCENCE
      • 5.3.1.1. Luciferins
      • 5.3.1.2. Proluciferins
      • 5.3.1.3. Coelenterazine
      • 5.3.1.4. Others
    • 5.3.2. FLUORESCENCE
      • 5.3.2.1. Green Fluorescent Proteins
      • 5.3.2.2. Red Fluorescent Proteins
      • 5.3.2.3. Infrared Dyes
      • 5.3.2.4. Others
  • 5.4. MRI CONTRAST REAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO)
    • 5.4.1. GADOLINIUM BASED
    • 5.4.2. IRON BASED
  • 5.5. CT CONTRASTREAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO)
    • 5.5.1. IODINE BASED
    • 5.5.2. BARIUM BASED
    • 5.5.3. GASTROGRAFIN BASED
  • 5.6. ULTRASOUND CONTRAST REAGENTS FOR SMALL ANIMAL IMAGING (IN VIVO)
    • 5.6.1. GADOLINIUM OXIDE ALBUMIN MICROSPHERES - GOAM

6. GEOGRAPHIC ANALYSIS

  • 6.1. INTRODUCTION
  • 6.2. NORTH AMERICA
  • 6.3. EUROPE
  • 6.4. ASIA-PACIFIC
  • 6.5. REST OF THE WORLD (ROW)

7. COMPETITIVE LANDSCAPE

  • 7.1. INTRODUCTION

8. COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 8.1. AGILENT TECHNOLOGIES, INC.
  • 8.2. ASPECT IMAGING
  • 8.3. BIOSCAN, INC.
  • 8.4. BIOSPACE LAB
  • 8.5. BRUKER CORPORATION
  • 8.6. FUJIFILM HOLDINGS CORPORATION
  • 8.7. GAMMA MEDICA-IDEAS, INC.
  • 8.8. GENOVIS AB
  • 8.9. LI-COR BIOSCIENCES
  • 8.10. LIFE TECHNOLOGIES CORPORATION
  • 8.11. MEDISO MEDICAL IMAGING SYSTEMS
  • 8.12. MILTENYI BIOTEC GMBH
  • 8.13. PERKINELMER, INC.
  • 8.14. PROMEGA CORPORATION
  • 8.15. SCANCO MEDICAL AG
  • 8.16. SIEMENS AG
  • 8.17. SOFIE BIOSCIENCES, INC.
  • 8.18. TARGESON, INC.
  • 8.19. UVP, LLC.

*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

LIST OF TABLES

  • TABLE 1: GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY SEGMENT, 2010 - 2017 ($MILLION)
  • TABLE 2: GLOBAL SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 3: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 4: GLOBAL PRE-CLINICAL STANDALONE IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 5: PRE-CLINICAL STANDALONE IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 6: GLOBAL PRE-CLINICAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 7: PRE-CLINICAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 8: MICRO-SPECT SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 9: MICRO-PET SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 10: GLOBAL PRE-CLINICAL OPTICAL IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 11: PRE-CLINICAL OPTICAL IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 12: PRE-CLINICAL FLUORESCENCE IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 13: PRE-CLINICAL BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 14: PRE-CLINICAL NEAR INFRARED FLUORESCENCE IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 15: MICRO-MRI SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 16: MICRO-CT SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 17: MICRO-ULTRASOUND SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 18: PRE-CLINICAL MULTIMODAL NUCLEAR IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 19: PRE-CLINICAL MULTIMODAL NUCLEAR IMAGINGSYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 20: PRE-CLINICAL SPECT/CT IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 21: PRE-CLINICAL SPECT-MRI IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 22: PRE-CLINICAL PET/CT IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 23: PRE-CLINICAL PET/MRI IMAGING SYSTEMS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 24: ADVANTAGES OF CLI OVER TRADITIONAL OPTICAL & NUCLEAR IMAGING TECHNIQUES
  • TABLE 25: GLOBAL SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS SYSTEMS MARKET, BY PRODUCT, 2010 - 2017 ($MILLION)
  • TABLE 26: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 27: GLOBAL PRE-CLINICAL NUCLEAR IMAGING RADIOTRACERS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 28: PRE-CLINICAL NUCLEAR IMAGING RADIOTRACERS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 29: GLOBAL SMALL ANIMAL IMAGING PET RADIOTRACERS MARKET, BY RADIOISOTOPES, 2010 - 2017 ($MILLION)
  • TABLE 30: SMALL ANIMAL IMAGING PET RADIOTRACERS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 31: EXAMPLES OF PET TRACERS USED IN ANIMAL IMAGING
  • TABLE 32: SMALL ANIMAL IMAGING FLUORINE-18 BASED RADIOTRACERS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 33: SMALL ANIMAL IMAGING CARBON-11 BASED RADIOTRACERS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 34: SMALL ANIMAL IMAGING COPPER-64 BASED RADIOTRACERS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 35: SMALL ANIMAL IMAGING OTHER PET RADIOTRACERS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 36: GLOBAL SMALL ANIMAL IMAGING SPECT PROBES MARKET, BY RADIOISOTOPES, 2010 - 2017 ($MILLION)
  • TABLE 37: SMALL ANIMAL IMAGING SPECT PROBES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 38: SMALL ANIMAL IMAGING TECHNETIUM-99M BASED PROBES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 39: SMALL ANIMAL IMAGING IODINE-131 BASED PROBES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 40: SMALL ANIMAL IMAGING GALLIUM-67 BASED PROBES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 41: SMALL ANIMAL IMAGING THALLIUM-201 BASED PROBES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 42: SMALL ANIMAL IMAGING OTHER SPECT PROBES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 43: GLOBAL PRE-CLINICAL OPTICAL IMAGING REAGENTS MARKET, BY PRODUCT, 2010 - 2017 ($MILLION)
  • TABLE 44: PRE-CLINICAL OPTICAL IMAGING REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 45: GLOBAL SMALL ANIMAL IMAGING BIOLUMINESCENT AGENTS MARKET, BY PRODUCT, 2010 - 2017 ($MILLION)
  • TABLE 46: SMALL ANIMAL IMAGING BIOLUMINESCENT AGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 47: PRE-CLINICAL LUCIFERINS IMAGING REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 48: PRE-CLINICAL PROLUCIFERINS IMAGING REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 49: PRE-CLINICAL COELENTERAZINE IMAGING REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 50: PRE-CLINICAL OTHER BIOLUMINESCENT IMAGING REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 51: GLOBAL PRE-CLINICAL FLUORESCENT IMAGING REAGENTS MARKET, BY PRODUCT, 2010 - 2017 ($MILLION)
  • TABLE 52: PRE-CLINICAL FLUORESCENT IMAGING REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 53: PRE-CLINICAL GREEN FLUORESCENT PROTEINS IMAGING REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 54: PRE-CLINICAL RED FLUORESCENT PROTEINS IMAGING REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 55: PRE-CLINICAL INFRARED DYES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 56: OTHER FLUORESCENT IMAGING AGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 57: GLOBAL SMALL ANIMAL IMAGING MRI CONTRAST REAGENTS MARKET, BY PRODUCT, 2010 - 2017 ($MILLION)
  • TABLE 58: SMALL ANIMAL IMAGING MRI CONTRAST REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 59: GADOLINIUM-BASED MRI IMAGING AGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 60: IRON-BASED MRI IMAGING AGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 61: GLOBAL SMALL ANIMAL IMAGING CT CONTRAST REAGENTS MARKET, BY PRODUCT, 2010 - 2017 ($MILLION)
  • TABLE 62: SMALL ANIMAL IMAGING CT CONTRAST REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 63: IODINE-BASED CT IMAGING AGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 64: BARIUM-BASED CT IMAGING AGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 65: GASTROGRAFIN-BASED CT IMAGING AGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 66: SMALL ANIMAL IMAGING ULTRASOUND CONTRAST REAGENTS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 67: SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
  • TABLE 68: NORTH AMERICA: SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 69: NORTH AMERICA: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 70: NORTH AMERICA: PRE-CLINICAL STANDALONE IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 71: NORTH AMERICA: PRE-CLINICAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 72: NORTH AMERICA: PRE-CLINICAL OPTICAL IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 73: NORTH AMERICA: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET, 2010 - 2017 ($MILLION)
  • TABLE 74: EUROPE: SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 75: EUROPE: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 76: EUROPE: PRE-CLINICAL STANDALONE IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 77: EUROPE: PRE-CLINICAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 78: EUROPE: PRE-CLINICAL OPTICAL IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 79: EUROPE: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 80: ASIA-PACIFIC: SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 81: ASIA-PACIFIC: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 82: ASIA-PACIFIC: PRE-CLINICAL STANDALONE IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 83: ASIA-PACIFIC: PRE-CLINICAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 84: ASIA-PACIFIC: PRE-CLINICAL OPTICAL IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 85: ASIA-PACIFIC: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 86: ROW: SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 87: ROW: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 88: ROW: PRE-CLINICAL STANDALONE IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 89: ROW: PRE-CLINICAL STANDALONE NUCLEAR IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 90: ROW: PRE-CLINICAL OPTICAL IMAGING SYSTEMS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 91: ROW: SMALL ANIMAL IMAGING AGENTS & RADIOTRACERS MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
  • TABLE 92: MERGERS & ACQUISITIONS, 2010 - 2012
  • TABLE 93: AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, 2010 - 2012
  • TABLE 94: NEW PRODUCT LAUNCH, 2009 - 2012
  • TABLE 95: EXPANSION, 2010 - 2012
  • TABLE 96: OTHER DEVELOPMENTS, 2009 - 2012
  • TABLE 97: AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 98: AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE, BY SEGMENT, 2009 - 2011 ($MILLION)
  • TABLE 99: AGILENT TECHNOLOGIES, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 100: BRUKER CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 101: BRUKER CORPORATION: TOTAL REVENUE, BY SEGMENT, 2009 - 2011($MILLION)
  • TABLE 102: BRUKER CORPORATION: TOTAL REVENUE, BY SEGMENT, 2009 - 2011 ($MILLION)
  • TABLE 103: BRUKER CORPORATION: TOTAL REVENUE, BY SCIENTIFIC INSTRUMENTS SEGMENTS, 2009 - 2011 ($MILLION)
  • TABLE 104: BRUKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 105: FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 - 2012 ($MILLION)
  • TABLE 106: FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENT, 2010 - 2012 ($MILLION)
  • TABLE 107: FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 - 2012 ($MILLION)
  • TABLE 108: GENOVIS AB: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($THOUSAND)
  • TABLE 109: GENOVIS AB: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($THOUSAND)
  • TABLE 110: LIFE TECHNOLOGIES CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
  • TABLE 111: LIFE TECHNOLOGIES CORPORATION: TOTAL REVENUE, BY SEGMENT, 2009 - 2011 ($MILLION)
  • TABLE 112: LIFE TECHNOLOGIES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 113: PERKINELMER INC: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 114: PERKINELMER INC: TOTAL REVENUE, BY SEGMENT, 2009 - 2011 ($MILLION)
  • TABLE 115: PERKINELMER, INC: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
  • TABLE 116: SIEMENS AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
  • TABLE 117: SIEMENS AG: TOTAL REVENUE, BY SEGMENT, 2009 - 2011 ($MILLION)
  • TABLE 118: SIEMENS AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY, 2012 VS 2017
  • FIGURE 2: GLOBAL SMALL ANIMAL IMAGING (IN VIVO) REAGENTS MARKET, BY TECHNOLOGY, 2012 VS 2017
  • FIGURE 3: SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY GEOGRAPHY, 2012
  • FIGURE 4: SMALL ANIMAL IMAGING (IN VIVO) TECHNOLOGIES MARKET SEGMENTATION
  • FIGURE 5: SMALL ANIMAL IMAGING (IN VIVO) MARKET SEGMENTATION
  • FIGURE 6: SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET SEGMENTATION
  • FIGURE 7: COMPARATIVE CHART ON SMALL ANIMAL IMAGING (IN VIVO) MODALITIES
  • FIGURE 8: SMALL ANIMAL IMAGING (IN VIVO) REAGENTS MARKET SEGMENTATION
  • FIGURE 9: MARKET DYNAMICS
  • FIGURE 10: GLOBAL SMALL ANIMAL IMAGING MARKET SHARE, BY TECHNOLOGY, 2012
  • FIGURE 11: GLOBAL SMALL ANIMAL IMAGING MARKET SHARE, BY KEY PLAYERS, 2012
  • FIGURE 12: GLOBAL PRE-CLINICAL NUCLEAR IMAGING MARKET SHARE, BY KEY PLAYERS, 2012
  • FIGURE 13: GLOBAL PRE-CLINICAL OPTICAL IMAGING MARKET SHARE, BY KEY PLAYERS, 2012
  • FIGURE 14: SMALL ANIMAL IMAGING SYSTEMS &REAGENTS MARKET SHARE, BY GEOGRAPHY, 2012 VS. 2017
  • FIGURE 15: GLOBAL PRE-CLINICAL STANDALONE SYSTEMS MARKET, BY TECHNOLOGY, 2012 VS 2017 ($MILLION)
  • FIGURE 16: APPLICATION AREAS OF CERENKOV LUMINESCENCE IMAGING
  • FIGURE 17: FORECAST MARKET LIFE CYCLE OF CLI TILL 2020
  • FIGURE 18: IMPACT OF DRIVERS & RESTRAINTS ON THE CLI MARKET
  • FIGURE 19: GLOBAL SMALL ANIMAL IMAGING REAGENTS & RADIOTRACERS SYSTEMS MARKET, BY PRODUCT,2010 - 2017 ($MILLION)
  • FIGURE 20: GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET SHARE, BY GROWTH STRATEGIES, 2010 - 2012
  • FIGURE 21: KEY PLAYERS FOCUSING ON NEW PRODUCT LAUNCH STRATEGY, 2010 - 2012
  • FIGURE 22: KEY PLAYERS FOCUSING ON PARTNERSHIPS & COLLABORATIONS STRATEGY, 2010 - 2012
  • FIGURE 23: KEY PLAYERS FOCUSING ON MERGERS & ACQUISITIONS STRATEGY, 2010 - 2012
Back to Top